Alterity Therapeutics (ATHE)

Alterity Therapeutics Ltd is a clinical-stage biotechnology company focused on neurodegenerative diseases and the creation of a chemical library of proprietary molecules. Its research and clinical development efforts are focused on Parkinson's disease and related disorders, where it is identifying and developing novel compounds that address the underlying pathology of these disorders by binding and redistributing excess labile iron, reducing alpha-synuclein aggregation, and rescuing neurons in the brain. Its pipeline programs are ATH434-201, ATH434-202, bioMUSE, ATH434, and Drug Discovery. The Group operated in one segment, research and development into Parkinsonian and other neurodegenerative disorders.

的Alterity Therapeutics Limited American Depositary Shares（ATHE）股票的价格今天是$3.43，自市场开启。该公司市值为$6217.11万，日交易量为$754.90股。前一交易日收盘价为 $3.43。

您准备好开始了吗？按照以下步骤操作，或阅读我们关于在Kraken上从10美元起购买Alterity Therapeutics股票的指南。